Estrogen and progesterone receptors, C-ERBB-2, p53, and BCL-2 in thirty-three invasive micropapillary breast carcinomas

Pathology Research and Practice

Volumn 192, Issue 1, 1996, Pages 27-32

  Luna More S ^a   De Los Santos, F ^a   Breton J J ^a   Canadas M A ^b  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b Histopat Laboratoris   (Spain)

Author keywords

Bcl 2; c erbB 2 (Her 2 Neu); Hormone receptors; Micropapillary breast carcinoma; p53

Indexed keywords

ESTROGEN RECEPTOR; HORMONE RECEPTOR; PARAFFIN; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL NUCLEUS; CELL TYPE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH VESSEL; METASTASIS; MITOSIS; ONCOGENE; ONCOGENE C ERB; PHENOTYPE; PROGNOSIS; TUMOR VOLUME;

EID: 0029918842     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(96)80126-9     Document Type: Article

References (34)

1. Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Mari S, Alhava E et al (1992) Histological assessment of the prognostic factors in female breast cancer. Oncology 49 (1): 1-8
2. Andersen J, Poulsen HS (1989) Immunohistochemical estrogen receptor determination in paraffin-embedded tissue. Cancer 64: 1901-1908
3. Battifora H, Gaffey M, Esteban J, Mehta P, Bailey A, Faucett C, Niland J (1991) Immunohistochemical assay of neu/c-erbB-2 oncogene product in paraffin-embedded tissues in early breast cancer: retrospective follow-up study of 245 stage I and II cases. Mod Pathol 4 (4): 466-474
4. Battifora H, Mehta P, Ahn C, Esteban JM (1993) Estrogen receptor immunohistochemical assay in paraffin-embedded tissue. Appl Immunohistochem 1 (1): 39-45
5. Benitez-Bribiesca L, Guevara R, Ruiz MT, Martínez G, Rodriguez-Cuevas S (1992) A simplified histoscore for the estrogen receptor assay in breast cancer. Path Res Pract 188: 461-465
6. Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63: 181-187
7. Davidoff AM, Kerns BJ, Pence JC, Marks JR, Iglehart JD (1991) p53 alterations in all stages of breast cancer. J Surg Oncol 48 (4): 260-267
8. Dawkins HJ, Robbins PD, Sarna M, Carrello S, Harvey JM, Sterrett GF (1993) c-erbB-2 amplification and overexpression in breast cancer: evaluation and comparison of Southern blot, slot blot, ELISA and immunohistochemistry. Pathology 25 (2): 124-132
9. De Potter CR (1994) The neu-oncogene: more than a prognostic indicator? Hum Pathol 25: 1264-1268
10. Eriksson ET, Schimmelpenning H, Aspenblad U, Zetterberg A, Auer GU (1994) Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease. Hum Pathol 25: 1228-1233
11. Fisher ER, Constantino J, Fisher B, Redmond C (1993) Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4). Discriminants for 15 year survival. Cancer 71: 2141-2150
12. Fisher ER, Gregono RM, Fisher B (1975) The pathology of invasive breast cancer: A syllabus derived from findings of the National Surgical Adjuvant Breast Project (Protocol No 4). Cancer 36: 1-85
13. Friedrichs K, Gluba S, Eidtmann H (1993) Overexpression of p53 and prognosis in breast cancer. Cancer 72 3641-3647
14. Haerslev T, Jacobsen GK (1995) An immunoshistochemical study of p53 with correlations to histopathological parameters, c-erbB-2, proliferatin cell nuclear antigen, and prognosis. Hum Pathol 26: 295-301
15. Harada Y, Katagiri T, Ito I, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y, Emi M (1994) Genetic studies of 457 breast cancers. Cancer 74: 2281-2286
16. Hartmann LC, Ingle JN, Wold LE, Farr GH, Grill JP, Su JQ, Maihle NJ, Krook JE, Witzig TE, Roche PC (1994) Prognostic value of c-erbB-2 overexpressin in axillary lymph node positive breast cancer. Cancer 74: 2956-2963
17. Hulka BS, Liu ET, Lininger RA (1994) Steroid hormones and risk of breast cancer. Cancer 74: 1111-1124
18. Kerns BJ, Jordan BA, Huper G, Marks JR, Iglehart JD, Layfield LJ (1993) Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer. Mod Pathol 6(6): 673-678
19. Korsmeyer SJ (1992) Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80(4): 879-886
20. Le Doussal V, Tubiana-Hulin M, Friedman S, Hacene K, Spyratos F, Brunet M (1989) Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer 64:1914-1921
21. Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL (1994) Bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 69 (1): 135-139
22. Leslie KO, Howard P (1992) Oncogenes and antioncogenes in human breast carcinoma. In: Rosen PP and Fechner RE (Ed) Pathology Annual Part 1, 321-342. Appleton & Lange, Norwalk, California
23. Luna-Moré S, Gonzalez B, Acedo C, Rodrigo I, Luna C (1994) Invasive micropapillary carcinoma of the breast: A new special type of invasive mammary carcinoma. Path Res Pract 190: 668-674
24. Mansour E, Ravdin PM (1994) Prognostic factors in early breast carcinoma. Cancer 74; 381-400
25. McCarty KS Jr, Barton T, Fetter BF, Woodard BH, Mossier JA, Reeves W, Daly J, Wilkinson WE, McCarty KS Sr (1980) Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma. Cancer 46: 2851-2858
26. Millis RR (1980) Correlation of hormone receptors with pathological features in human breast cancer. Cancer 46: 2869-2871
27. Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP (1980) Management and survival of female breast cancer. Cancer 45: 2917-2924
28. Orbo A, Stalsberg H, Kinde D (1990) Topographic criteria in the diagnosis of tumor emboli in intramammary lymphatics. Cancer 66: 972-977
29. Page DL (1991) Prognosis and breast cancer. Am J Surg Pathol 15 (4): 334-349
30. Petersen JL (1993) Breast carcinoma with an unexpected inside out growth pattern, rotation of polarisation associated with angioinvasion. Path Res Pract 189: 780
31. Silvestrini R, Veneroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, Di Fronzo G, Rilke F, Veronesi U (1994) The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 86 (7): 499-504
32. Sundblad AS, Ahn C, Mehta P, Caprarulo L, Battifora M (1992) The immunohistochemical determination of hormonal receptors in breast cancer. A retrospective study in 322 cases. Medicina (B Aires) 52 (4): 333-340
33. Tetu B, Brisson J (1993) Prognostic significance of Her 2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunstaining and adjuvant therapy. Cancer (73): 2359-2365
34. Thor AD, Moore DH, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH (1992) Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84 (11): 845-855